Search - tctmd.com

Displaying 1 - 20 of 55

Sort: Relevancy | Date

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Conference News ESC 2025

NEWTON-CABG CardioLink-5: Evolocumab Doesn’t Prevent SVG Failure

Michael O'Riordan

September 04, 2025

News Daily News

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Todd Neale

July 16, 2025

News Conference News European Congress on Obesity 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Daily News

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Michael O'Riordan

March 06, 2025

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News Daily News

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

Michael O'Riordan

June 30, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Conference News ACC 2023

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Caitlin E. Cox

March 14, 2023

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

News Conference News EAS 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News EuroPCR 2022

Registry Data Hint at MACE Benefit With Renal Denervation

Michael O'Riordan

May 17, 2022

News Daily News

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Caitlin E. Cox

April 15, 2022

News Conference News ACC 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Michael O'Riordan

April 03, 2022

News Daily News

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Michael O'Riordan

January 25, 2022

Advertisement

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

NEWTON-CABG CardioLink-5: Evolocumab Doesn’t Prevent SVG Failure

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Will Semaglutide Change Cardiac Surgery? It Already Has

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Polypill Bests Usual Care in Patients With Recent MI: SECURE

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Registry Data Hint at MACE Benefit With Renal Denervation

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content